autologous CAR-engineered regulatory T cells SBT777101
Term · Oncology and biomedicine · MLC-T-ONC-011525
A preparation of autologous T-regulatory cells (Tregs) that have been genetically modified to express a chimeric antigen receptor (CAR) targeting citrullinated proteins, with potential immunmodulating activity. Upon administration, the autologous CAR-engineered regulatory T cells SBT777101 target and bind to citrullinated proteins and may decrease inflammation and promote immunologic homeostasis. Citrullinated proteins are found in inflamed disease-associated tissues in many autoimmune and inflammatory diseases.
| Identifier | MLC-T-ONC-011525 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | autologous CAR-engineered Treg cells SBT777101; autologous CAR-Treg cells SBT777101; autologous CAR-Tregs SBT-77-7101 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011525",
"term": "autologous CAR-engineered regulatory T cells SBT777101",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous T-regulatory cells (Tregs) that have been genetically modified to express a chimeric antigen receptor (CAR) targeting citrullinated proteins, with potential immunmodulating activity. Upon administration, the autologous CAR-engineered regulatory T cells SBT777101 target and bind to citrullinated proteins and may decrease inflammation and promote immunologic homeostasis. Citrullinated proteins are found in inflamed disease-associated tissues in many autoimmune and inflammatory diseases.",
"synonyms": [
"autologous CAR-engineered Treg cells SBT777101",
"autologous CAR-Treg cells SBT777101",
"autologous CAR-Tregs SBT-77-7101"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-car-engineered-regulatory-t-cells-sbt777101/"
}
Record 2,859 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.